Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?

Overview of attention for article published in Biomedicine & Pharmacotherapy, February 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 5 news outlets
twitter: 4 X users

reddit: 1 Redditor

Readers on

mendeley: 188 Mendeley

So far, Altmetric has seen 7 news stories from 5 outlets.

La detección de silico y la validación experimental identifican la riboflavina como un antiviral dirigido a ARN contra SARS-CoV-2

Espanol.news, 23 Aug 2025

Chakraborty, C., Sharma, AR, Bhattacharya, M., Agoramoorthy, G. y Lee, SS La reutilización de fármacos para los ensayos clínicos…

В скрининге и экспериментальной валидации Silico идентификация рибофлавина как антивирусное противовирусное средство для РНК против SARS-COV-2 - Mandarinian

Mandarinian, 23 Aug 2025

Chakraborty, C., Sharma, AR, Bhattacharya, M., Agoramoorthy, G.

Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells | BMC Infectious Diseases

Health Reporter, 05 Oct 2024

Stanford Was Conducting a Long COVID Study. Then the Staff Stopped Masking.

Yahoo! News, 06 May 2023

A clinical trial run by Stanford Medicine to study the use of Paxlovid to fight long COVID was rocked last week, when it was…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 3 additional news stories.